Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127242751 | 12724275 | 1 | I | 201608 | 20160830 | 20160908 | 20160908 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-56851BP | BOEHRINGER INGELHEIM | 72.83 | YR | M | Y | 0.00000 | 20160908 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127242751 | 12724275 | 1 | PS | COMBIVENT | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | Respiratory (inhalation) | DOSE PER APPLICATION: 20 MCG / 100 MCG; DAILY DOSE: 80MCG / 400MCG | 507343A | 21747 | PRESSURISED INHALATION | QID | |||||||
| 127242751 | 12724275 | 2 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 6.25 MG | 0 | 3.125 | MG | TABLET | BID | ||||||
| 127242751 | 12724275 | 3 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 80 MG | 0 | 40 | MG | TABLET | BID | ||||||
| 127242751 | 12724275 | 4 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 40 MG | 0 | 40 | MG | TABLET | QD | ||||||
| 127242751 | 12724275 | 5 | C | BUPROPION HCL | BUPROPION HYDROCHLORIDE | 1 | Oral | 300 MG | 0 | 300 | MG | TABLET | QD | ||||||
| 127242751 | 12724275 | 6 | C | ZETIA | EZETIMIBE | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
| 127242751 | 12724275 | 7 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG | 0 | 75 | MG | TABLET | QD | ||||||
| 127242751 | 12724275 | 8 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 100 MG | 0 | 100 | MG | TABLET | QD | ||||||
| 127242751 | 12724275 | 9 | C | XYZAL | LEVOCETIRIZINE DIHYDROCHLORIDE | 1 | Oral | 5 MG | 0 | 5 | MG | TABLET | QD | ||||||
| 127242751 | 12724275 | 10 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 20 MG | 0 | 20 | MG | TABLET | QD | ||||||
| 127242751 | 12724275 | 11 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG | 0 | 81 | MG | TABLET | QD | ||||||
| 127242751 | 12724275 | 12 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Oral | 2.5 MG | 0 | 2.5 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127242751 | 12724275 | 1 | Product used for unknown indication |
| 127242751 | 12724275 | 2 | Product used for unknown indication |
| 127242751 | 12724275 | 3 | Gastric disorder |
| 127242751 | 12724275 | 4 | Blood cholesterol decreased |
| 127242751 | 12724275 | 5 | Anxiety |
| 127242751 | 12724275 | 6 | Blood cholesterol decreased |
| 127242751 | 12724275 | 7 | Myocardial infarction |
| 127242751 | 12724275 | 8 | Diabetes mellitus |
| 127242751 | 12724275 | 9 | Upper-airway cough syndrome |
| 127242751 | 12724275 | 10 | Anxiety |
| 127242751 | 12724275 | 11 | Cardiac disorder |
| 127242751 | 12724275 | 12 | Diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127242751 | 12724275 | Cough | |
| 127242751 | 12724275 | Tongue discomfort |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127242751 | 12724275 | 1 | 201607 | 0 |